Featured on CNN: First human trial of potential antibody treatment for Covid-19 begins

“Eli Lilly and Company said Monday it has started the first human trial of an antibody therapy designed to treat Covid-19… The treatment was created in collaboration with AbCellera, a biotechnology company based in Canada.”

Read full coverage on CNN.

PARTNERSHIP

Together we can make game-changing discoveries.